David Puleo

David Puleo has a diverse work experience in the field of scientific research and development. David started their career at Novartis Institutes for BioMedical Research (NIBR), where they worked as a Scientific Associate I from June 2010 to May 2011 and later as a Scientific Associate II from June 2011 to July 2012. David then joined Yale University in August 2012 as a Ph.D. Candidate and worked there until October 2018. During their time at Yale, they also served as a Postdoctoral Associate from November 2018 to February 2019. In February 2019, David joined Halda Therapeutics as a Senior Research Scientist and worked there until September 2020. David then transitioned to the role of Research Investigator at Halda Therapeutics from October 2020 to October 2022. Currently, David is working as the Principal Scientist at Halda Therapeutics since November 2022.

David Puleo completed their Bachelor of Science degree in Biochemistry at Boston College from 2006 to 2010. Following this, they pursued their Doctor of Philosophy (PhD) in Pharmacology at Yale University, where they studied from 2012 to 2018.